About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportAdvancing community oncology care and expanding our differentiated value proposition
Establishing new ventures to broaden our scope as a diversified healthcare services leader
Responding to global healthcare needs and expanding patient support services
Investing in solutions to improve patient outcomes
Forging new strategic ventures to expand healthcare expertise
Transforming the fight against cancer
Accelerating global leadership in healthcare
Building a best-in-class supply chain
McKesson has mobilized resources during some of the most threatening health crises throughout history. From distributing medicines and vaccines to deploying personal protective equipment (PPE), the company has been dedicated to making care possible for more than 190 years.
1833 - McKesson is founded by John McKesson and Charles Olcott to import and sell therapeutic drugs and herbal products.
1918 – A severe flu pandemic infects a third of the world’s population, claiming the life of an estimated 50 million people worldwide. McKesson distributes lozenges with the hope of preventing the spread of the deadly influenza.
1940s – Penicillin becomes widely available to reduce illness and death from infectious diseases. McKesson Laboratories deploys an experimental production of penicillin carrying it out under license by the government. The company is officially recognized by the War Production Board for its part in this wartime effort.
2005 – Hurricane Katrina, one of the deadliest hurricanes in U.S. history, impacts many communities including New Orleans. McKesson reacts to help the most vulnerable get access to critical medications. Stronger emergency-response plans across the healthcare industry emerge after the crisis to strengthen the healthcare supply chain through collaboration with public health and private sectors by addressing pressing issues before, during, and after disasters.
2006 – Uninsured and underinsured children are threatened without access to vaccines. McKesson is selected by the Center for Disease Control (CDC) to distribute vaccines for the Vaccines for Children Program to reach more than 1.8 million children via approximately 44,000 participating healthcare provider sites.
2009 – H1N1 Flu poses a major threat to human health. McKesson partners with the CDC as the sole vaccine distributor. The company deploys over 125 million doses to as many as 90,000 sites across the U.S., making it the largest public health initiative of the time.
2014 – Ebola breaks out in West Africa with more than 21,000 cases. McKesson responds with a donation of medical relief supplies, including 4 million pairs of latex gloves, 8,000 gallons of disinfectant and personal protective equipment kits.
2020-2021 – The World Health Organization declares the COVID-19 outbreak a pandemic on March 11, 2020. McKesson uses its longstanding expertise in managing complex logistics to partner with the U.S. government to deliver critically needed medical supplies to frontline healthcare workers across the country. Additionally, McKesson continues distributing medications daily to pharmacies in North America and Europe.
Under Emergency Use Authorization, the company is distributing Moderna’s COVID-19 vaccine and Johnson & Johnson's COVID-19 vaccine as directed by the U.S. government. Additionally, the company is distributing the ancillary supplies needed to administer Moderna, Johnson & Johnson and Pfizer vaccines.